Antibodies in celiac disease: Implications beyond diagnostics

Cellular and Molecular Immunology

Volumn 8, Issue 2, 2011, Pages 103-109

  Caja, Sergio ^a   Mäki, Markku ^a   Kaukinen, Katri ^a   Lindfors, Katri ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

antibody; celiac disease; diagnostics; pathogenesis

Indexed keywords

AUTOANTIBODY; DEAMIDATED GLIADIN PEPTIDE ANTIBODY; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2 ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 3 ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 6 ANTIBODY; RETICULIN TYPE R1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELIAC DISEASE; CLINICAL FEATURE; HUMAN; HUMORAL IMMUNITY; HYPERPLASIA; IMMUNOPATHOGENESIS; INTESTINE BIOPSY; INTESTINE CRYPT; INTESTINE VILLUS ATROPHY; REVIEW; SERODIAGNOSIS; SMALL INTESTINE MUCOSA;

ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNITY; CELIAC DISEASE; HUMANS;

EID: 79952364787     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.65     Document Type: Review

References (93)

1. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26: 1217-1225. (Pubitemid 47620425)
2. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003; 348: 2517-2524. (Pubitemid 36706539)
3. Vilppula A, Kaukinen K, Luostarinen L, Krekelä I, Patrikainen H, Valve R et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMcGastroenterol 2009; 9: 49.
4. Mustalahti K, Collin P, Sievänen H, Salmi J, Mäki M. Osteopenia in patients with clinically silent coeliac disease warrants screening. Lancet 1999; 354: 744-745. (Pubitemid 29405795)
5. Fry L. Dermatitis herpetiformis. Baillieres Clin Gastroenterol 1995; 9: 371-393.
6. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gutto brain. Lancet Neurol 2010; 9: 318-330.
7. Rubio-Tapia A, Murray JA. The liver in celiac disease. Hepatology 2007; 46: 1650-1658. (Pubitemid 350155546)
8. Chakravarty K, Scott DG. Oligoarthritis\a presenting feature of occult coeliac disease. Br J Rheumatol 1992; 31: 349-350.
9. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology 2005; 129: 454-463. (Pubitemid 41096633)
10. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464-483.
11. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L et al. H L Atypes in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003; 64: 469-477. (Pubitemid 36373778)
12. Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A et al. Genomewide linkage analysisof celiac disease in Finnish families. Am J Hum Genet 2002; 70: 51-59. (Pubitemid 34031697)
13. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A et al. Multiplecommon variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42: 295-302.
14. Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 2002; 283: G996-G1003. (Pubitemid 35033943)
15. Shan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM et al.Structural basisforgluten intolerance in celiac sprue. Science 2002; 297: 2275-2279.
16. Smecuol E, Bai JC, Vazquez H, Kogan Z, Cabanne A, Niveloni S et al. Gastrointestinal permeability in celiac disease. Gastroenterology 1997; 112: 1129-1136. (Pubitemid 27157523)
17. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003; 362: 30-37. (Pubitemid 36835817)
18. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J et al. Adirect rolefor NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004; 21:367-377. (Pubitemid 39208338)
19. Cinova J, Palova-Jelinkova L, Smythies LE, Cerna M, Pecharova B, Dvorak M et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 2007; 27: 201-209. (Pubitemid 46348718)
20. Nikulina M, Habich C, Flohe SB, Scott FW, Kolb H. Wheat gluten causes dendritic cell maturation and chemokine secretion. J Immunol 2004; 173: 1925-1933. (Pubitemid 38971628)
21. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-717. (Pubitemid 28274673)
22. Vader LW, de Ru A, van der Wal Y, Kooy YM, Benckhuijsen W, Mearin ML et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 2002; 195: 643-649. (Pubitemid 34461509)
23. Vande Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998; 161: 1585-1588. (Pubitemid 28387571)
24. Alaedini A, Green PH. Autoantibodies inceliac disease. Autoimmunity 2008; 41: 19-26.
25. Rostom A, Dubé C, Cranney A, Saloojee N, Sy R, Garritty C et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128:S38-S46. (Pubitemid 40460820)
26. Mäki M, Hällström O, Vesikari T, Visakorpi JK. Evaluation of a serum Ig A-class reticulin antibody test for thedetection of childhood celiac disease. J Pediatr 1984; 105: 901-905. (Pubitemid 15185315)
27. Sulkanen S, Halttunen T, Laurila K, Kolho KL, Korponay-Szabo IR, Sarnesto A et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detectingceliac disease. Gastroenterology 1998; 115: 1322-1328. (Pubitemid 28545980)
28. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptideantibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010; 31: 73-81.
29. Mäki M. The humoral immunesystem in coeliac disease. In: Howdle PD (ed.) Coeliac disease. Baillière's Clinical Gastroenterology 1995; 9: 231-249.
30. Seah PP, Fry L, Hoffbrand AV, Holborow EJ. Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet 1971; 1: 834-836.
31. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V. Ig Aclass endomysiumantibodies in dermatitis herpetiformis andcoeliacdisease. Ann N Y Acad Sci 1983; 420: 325-334. (Pubitemid 14147738)
32. Mäki M, Holm K, Lipsanen V, Hällström O, Viander M, Collin P et al. Serological markers and H L Agenes among healthy first-degree relatives of patients with coeliac disease. Lancet 1991; 338: 1350-1353.
33. Volta U, Molinaro N, de Franceschi L, Fratangelo D, Bianch FB. Ig A antiendomysial antibodytest. Astepforward in celiacdiseasescreening. Dig Dis Sci 1991; 36: 752-756.
34. Kurppa K, Collin P, Viljamaa M, Haimila K, Saavalainen P, Partanen J et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009; 136: 816-823.
35. Kurppa K, Ashorn M, Iltanen S, Koskinen LL, Saavalainen P, Koskinen O et al. Celiac disease without villous atrophy in children: a prospective study. J Pediatr 2010; 157: 373-380.
36. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO et al. Identification of tissue transglutaminase as the autoantigen of coeliac disease. Nat Med 1997; 3:797-801. (Pubitemid 27298728)
37. Dieterich W, Laag E, Schopper H, Volta U, Ferguson A, Gillett H et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115:1317-1321. (Pubitemid 28545979)
38. Korponay-Szabo IR, Laurila K, Szondy Z, Halttunen T, Szalai Z, Dahlbom I et al. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockouttissues. Gut 2003; 52: 199-204. (Pubitemid 36115059)
39. Lock RJ, Stevens S, Pitcher MC, Unsworth DJ. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease. Eur J Gastgroenterol Hepatol 2004; 16: 467-470. (Pubitemid 38586474)
40. Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool BMJ 2007; 334: 729.
41. Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB et al. Evaluation of Ig G antibodies against tissuetransglutaminaseas a diagnostic tool for coeliac disease. Gut 2003; 52: 1567-1571. (Pubitemid 37363439)
42. Collin P, Mäki M, Keyriläinen O, Hällström O, Reunala T, Pasternack A. Selective Ig A deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367-371.
43. Kurppa K, Lindfors K, Collin P, Saavalainen P, Partanen J, Haimila K et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol; in press. Doi:10.1097/MCG.Ob013e 3181fbdfa6.
44. Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR et al. Immunereaction against cytoskeleton in coeliac disease. Gut 2000; 47: 520-526.
45. Shiner M, Ballard J.Antigen-antibodyreactionsinjejunal mucosa inchildhoodcoeliac disease after gluten challenge. Lancet 1972; 1: 1202-1205.
46. Savilahti E. Intestinal immunoglobulins in children with coeliac disease. Gut 1972; 13:958-964.
47. Jos J, Labbe F. Ultrastructural localization of Ig A globulins in normal and coeliac intestinal mucosa using immunoenzymatic methods. Biomedicine 1976; 24: 425-434. (Pubitemid 8018942)
48. Lancaster-Smith M, Packer S, Kumar PJ, Harries JT. Immunological phenomena in the jejunum and serum after reintroduction of dietarygluten in children with treated coeliac disease. J Clin Pathol 1976; 29: 592-597.
49. Jos J, Labbe F, Geny B, Griscelli C Immunoelectron-microscopic localization of immunoglobulin A and secretory component in jejunal mucosa from children with coeliac disease. Scand J Immunol 1979; 9: 441-450. (Pubitemid 9179572)
50. Lancaster-Smith M, Joyce S, Kumar P. Immunoglobulins in the jejunal mucosa in adult coeliac disease and dermatitis herpetiformis afterthe reintroduction of dietary gluten. Gut 1977; 18: 887-891. (Pubitemid 8230166)
51. Rantala I, Mäki M, Laasonen A, Visakorpi JK. Periodate-lysine- paraphormaldehyde as a fixative for the study of duodenal mucosa. Morphologic and immunohistochemical results at light and electron microscopic levels. Acta Pathol Microbiol Scand A 1985; 93:165-173. (Pubitemid 15000630)
52. Karpati S, Kosnai I, Török E, Kovacs JB. Immunoglobulin A deposition in jejunal mucosa of children with dermatitis herpetiformis. J Invest Dermatol 1988; 91: 336-339.
53. Koskinen O, Villanen M, Korponay-Szabo I, Lindfors K, Mäki M, Kaukinen K. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease. J Pediatr Gastroenterol Nutr8; 559-565.2009;
54. Korponay-Szabo IR, Sulkanen S, Halttunen T, Maurano F, Rossi M, Mazzarella G et al. Tissue transglutaminase is the target in both rodent and primate tissues for celiac disease-specific autoantibodies. J Pediatr Gastroenterol Nutr 2000; 31: 520-527.
55. Korponay-Szabo IR, Halttunen T, Szalai Z, Laurila K, Kiraly R, Kovacs JB et al. Invivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53: 641-648. (Pubitemid 38561440)
56. Salmi TT, Collin P, Korponay-Szabo IR, Laurila K, Partanen J, Huhtala H et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibodydeposits. Gut 2006; 55: 1746-1753. (Pubitemid 44893572)
57. Marzari R, Sblattero D, Florian F, Tongiorgi E, Not T, Tommasini A et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001; 166: 4170-4176. (Pubitemid 32224950)
58. Koskinen O, Collin P, Lindfors K, Laurila K, Mäki M, Kaukinen K. Usefulnessof small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol 2010; 44: 483-488.
59. Koskinen O, Collin P, Korponay-Szabo I, Salmi T, Iltanen S, Haimila K et al. Gluten-dependentsmall bowel mucosal transglutaminase2-specific Ig Adeposits inovertand mild enteropathy coeliac disease. J Pediatr Gastroenterol Nutr 2008; 47: 436-442.
60. Kaukinen K, Peräaho M, Collin P, Partanen J, Woolley N, Kaartinen T et al. Small-bowel mucosal transglutaminase 2-specific Ig A deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol 2005; 40: 564-572. (Pubitemid 40676250)
61. Borrelli M, Maglio M, Agnese M, Paparo F, Gentile S, Colicchio B et al. Highdensityof intraepithelial gammadelta lymphocytesand depositsof immunoglobulin (Ig)M anti-tissue transglutaminase antibodies in the jejunum of coeliac patients with Ig A deficiency. Clin Exp Immunol 2010; 160: 199-206.
62. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997; 49: 29-34.
63. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (T Gase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747-757. (Pubitemid 34259719)
64. Hull CM, Liddle M, Hansen N, Meyer LJ, Schmidt L, Taylor T et al. Elevation of Ig A anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol 2008; 159: 120-124. (Pubitemid 351874506)
65. Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I. Autoantibodies against epidermal transglutaminasearea sensitivediagnostic marker in patientswith dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol 2009; 61: 39-43.
66. Hadjivassiliou M, Mäki M, Sanders DS, Williamson CA, Grunewald RA, Woodroofe NM et al. Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia. Neurology 2006; 66: 373-377. (Pubitemid 43739939)
67. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008; 64: 332-343.
68. Lindfors K, Koskinen O, Laurila K, Collin P, Saavalainen P, Haimila K et al. Ig A-class autoantibodies against neuronal transglutaminase, TG6 in celiac disease: no evidence for gluten dependency. Clin Chim Acta 2010; 9: 744-749.
69. Halttunen T, Mäki M. Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation. Gastroenterology 1999; 116: 566-572. (Pubitemid 29106764)
70. Barone MV, Caputo I, Ribecco MT, Maglio M, Marzari R, Sblattero D et al. Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. Gastroenterology 2007; 132: 1245-1253. (Pubitemid 46627567)
71. Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S et al. Inceliacdisease, a subset of autoantibodies against transglutaminase binds Toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006; 3: e358.
72. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, Menard S, Candalh C et al. Secretory Ig A mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008; 205: 143-154. (Pubitemid 351185722)
73. Rauhavirta T, Kaukinen K, Mäki M, Lindfors K. Coeliacdisease- specific Ig Aenhances the transepithelial passage of gliadin peptides. Clin Exp Immunil. In press. Doi: 10.1111/j.1365-2249.2010.04317.
74. Caputo I, Barone MV, Lepretti M, Martucciello S, Nista I, Troncone R et al. Celiac antitissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. Biochim Biophys Acta 2010; 1802:717-727.
75. Myrsky E, Kaukinen K, Syrjänen M, Korponay-Szabo IR, Mäki M, Lindfors K. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis. Clin Exp Immunol 2008; 152: 111-119. (Pubitemid 351347552)
76. Caja S, Myrsky E, Korponay-Szabo IR, Nadalutti C, Sulic AM, Lavric M et al. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac diseaseautoantibodies. Scand J Gastroenterol 2010; 45: 421-427.
77. Myrsky E, Caja S, Simon-Vecsei Z, Korponay-Szabo IR, Nadalutti C, Collighan R et al. Celiac disease Ig A modulates vascular permeability in vitro through the activity of transglutaminase 2 and Rho A. Cell Mol Life Sci 2009; 66: 3375-3385.
78. Cervio E, Volta U, Verri M, Boschi F, Pastoris O, Granito A et al. Sera of patients with celiacdiseaseand neurologicdisordersevokeamitochondrial- dependentapoptosis in vitro. Gastroenterology 2007; 133: 195-206. (Pubitemid 47031138)
79. Anjum N, Baker PN, Robinson NJ, Aplin JD. Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity. Reprod Biol Endocrinol 2009; 7: 16.
80. Di Simone N, Silano M, Castellani R, Di Nicuolo F, D'Alessio MC, Franceschi F et al. Anti-tissue transglutaminase antibodies from celiac patients are responsible for trophoblast damage via apoptosis in vitro. Am J Gastroenterol 2010; 105: 2254-2261.
81. Boscolo S, Lorenzon A, Sblattero D, Florian F, Stebel M, Marzari R et al. Anti transglutaminase antibodies cause ataxia in mice. PLoS One 2010; 5: e9698.
82. Di Niro R, Sblattero D, Florian F, Stebel M, Zentilin L, Giacca M et al. Anti-idiotypic response in miceexpressinghuman autoantibodies. Mol Immunol 2008; 45: 1782-1791.
83. Smart CJ, Trejdosiewicz LK, Howdle PD. Specific circulating anti-gliadin Ig G-class antibodydoes not mediate intestinal enteropathy in gliadin-fed mice. Int Arch Allergy Immunol 1992; 97: 160-166.
84. Freitag T, Schulze-Koops H, Niedobitek G, Melino G, Schuppan D. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease. Autoimmun Rev 2004; 3: 13-20. (Pubitemid 38293361)
85. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009; 9: 858-870.
86. Myrsky E, Syrjänen M, Korponay-Szabo IR, Mäki M, Kaukinen K, Lindfors K. Altered small-bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol 2009; 44: 162-167.
87. Haroon ZA, Hettasch JM, Lai TS, Dewhirst MW, Greenberg CS. Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healingand angiogenesis. Faseb J 1999; 13: 1787-1795. (Pubitemid 29473340)
88. de Kauwe AL, Chen Z, Anderson RP, Keech CL, Price JD, Wijburg O et al. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific antigliadin CD41 T cells. J Immunol 2009; 182: 7440-7450.
89. Marietta E, Black K, Camilleri M, Krause P, Rogers RS3rd, David C et al. Anewmodel for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 2004; 114: 1090-1097. (Pubitemid 39578698)
90. Sugai E, CherñavskyA, Pedreira S, Smecuol E, Vazquez H, Niveloni S et al. Bone-specific antibodies in sera from patients with celiac disease: characterization and implications in osteoporosis. J Clin Immunol 2002; 22: 353-362. (Pubitemid 35305885)
91. Naiyer AJ, Shah J, Hernandez L, Kim SY, Ciaccio EJ, Cheng J et al. Tissue transglutaminase antibodies in individuals with celiac disease bind to thyroid follicles and extracellular matrix and may contributeto thyroid dysfunction. Thyroid 2008;18: 1171-1178.
92. Sategna-Guidetti C, Franco E, Martini S, Bobbio M. Binding by serum Ig A antibodies from patients with coeliac disease to monkey heart tissue. Scand J Gastroenterol 2004;39:540-543. (Pubitemid 38916258)
93. McQueen F, Elliott B. B cell lymphoproliferation and organ-directed self-recognition to explain autoimmunity: backtothe past. Med Hypotheses 2010; 75: 328-333.